Acoustic Stimulation for Seizure Suppression



Status:Enrolling by invitation
Conditions:Neurology, Epilepsy
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:18 - 60
Updated:10/26/2018
Start Date:August 17, 2017
End Date:March 17, 2019

Use our guide to learn which trials are right for you!

Low Frequency Acoustic Stimulation During Sleep for Seizure Suppression

The objective of this study is to test the feasibility and physiological effect of
low-frequency (1 Hz) acoustic stimulation delivered during nocturnal NREM sleep in epilepsy
patients. The long-term goal is to develop this protocol for daily, long-term use in a home
setting, for nocturnal seizure and IED suppression

1. To test the feasibility of wearing an earphone system delivering acoustic stimulation
during a night of sleep in adult epilepsy patients monitored in an inpatient unit.

2. To determine the acute physiological effects of low-frequency acoustic stimulation on
interictal epileptiform discharge (IED) frequency during NREM sleep in adult patients
with epilepsy in an ambulatory setting.

3. To determine the feasibility of applying low-frequency acoustic stimulation in a
long-term home setting in adult epilepsy patients with frequent nocturnal seizures.

Inclusion Criteria:

- 18-60 years old

- Able to provide informed consent

- MOCA ≥26

- Fluent in English

- Frequent nocturnal IEDs (≥ 10% of the sleep record)

- Monitored on the adult epilepsy monitoring unit (EMU, for Aim 1 only) Additional
inclusion criteria for Aim 3

- Frequent nocturnal seizures (≥1 per week)

Exclusion Criteria:

- Hearing impairment

- Diagnosis of a sleep disorder (sleep apnea, periodic limb movements of sleep, or other
medical conditions with frequent arousals)

- Psychoactive medication use (other than AEDs, for example SSRIs, antipsychotics, BDZ,
or stimulants)

- Seizures ≤ 24 hours prior to study.

- Alcohol or recreational drug use in the 24 hours prior to the study

- BMI ≥ 30

- MOCA <26

- History of recent travel across time zones within the 1 month prior to study
activities

- Shift work for 1 month prior to study activities Additional Exclusion Criteria for Aim
3

- No medication changes at least 1 month before study, and during 3 months of study
activities
We found this trial at
1
site
550 1st Ave
New York, New York 10016
(212) 263-7300
Principal Investigator: Anli Liu, MD
New York University School of Medicine NYU School of Medicine has a proud history that...
?
mi
from
New York, NY
Click here to add this to my saved trials